<DOC>
	<DOCNO>NCT03028519</DOCNO>
	<brief_summary>This study evaluate serum vitamin D ( 25 ( OH ) D ) serum leptin level time diagnosis ovarian , primary peritoneal , and/or fallopian tube cancer well vitamin D receptor mutation status ( FokI SNP genotype ) . The study evaluate impact vitamin D repletion serum vitamin D level , serum leptin level , treatment-related morbidity patient .</brief_summary>
	<brief_title>Vitamin D , Leptin , Vitamin D Receptor Polymorphism , Treatment-Related Morbidity Ovarian Cancer</brief_title>
	<detailed_description>This study contain 2 cohort : normal serum 25 ( OH ) D low serum 25 ( OH ) D enrollment . The study take place woman ovarian , primary peritoneal , fallopian tube cancer . Patients give write consent enroll study serum 25 ( OH ) D level , serum leptin level , vitamin D receptor FokI single nucleotide polymorphism analyzed time diagnosis . Patients vitamin D deficiency prescribe vitamin D supplementation accord current guideline . Treatment cholecalciferol impact cancer therapy . Participants treatment course information collect prospectively , dictate study . Serum 25 ( OH ) D leptin level collect completion primary therapy , 6 month completion primary therapy , time disease recurrence . If patient remain vitamin D deficient follow-up time point , refer endocrinologist work-up treatment vitamin D deficiency . Data collection continue 1 year enrollment .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Patients must histologic diagnosis ovarian , fallopian tube , primary peritoneal carcinoma per pretreatment biopsy laparoscopy , interventional radiology , paracentesis , CT guide core biopsy . Histologic documentation original primary tumor require via pathology report . Patients must adequate : Renal function : Glomerular Filtration Rate ( GFR ) &gt; 30 ; Gastrointestinal absorption : No underlie malabsorption syndrome ( i.e . inflammatory bowel disease , celiac disease ) Ability tolerate oral medication Patients take vitamin D time enrollment without diagnosis vitamin D deficiency Patients childbearing potential must negative pregnancy test prior study entry practice effective form contraception . If applicable , patient must discontinue breastfeed prior study entry . Patients must least 18 year old Patients know preexist diagnosis vitamin D deficiency . Patients renal disease GFR &lt; 30 Patients primary hyperparathyroidism Patients invasive malignancy , exception nonmelanoma skin cancer . Patients concomitant endometrial cancer diagnose time ovarian cancer allow participate endometrial cancer International Federation Gynecology Obstetrics stage 1B less . Patients childbearing potential , practice adequate contraception , patient pregnant , patient breastfeed eligible trial .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>